Levetiracetam Glenmark

Levetiracetam, the active ingredient in Levetiracetam Glenmark, is an anticonvulsant presented as an oral dosage form for oral use. It is indicated for the treatment of partial seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients with epilepsy.

GNH USA supplies Levetiracetam Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is manufactured under GMP conditions, ensuring consistent quality for global distribution. It is available in bulk quantities to meet the needs of large healthcare institutions.

Levetiracetam is an antiepileptic medication that reduces seizure activity by modulating neuronal excitability.

Partial seizures: helps control focal onset seizures, decreasing frequency and severity. Generalized tonic‑clonic seizures: reduces occurrence of convulsive seizures, improving overall seizure control. Myoclonic seizures: diminishes rapid muscle jerks, aiding in seizure management for patients with myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: occasional light‑headed sensation - Fatigue: feeling of reduced energy - Headache: mild to moderate pain - Somnolence: increased sleepiness during the day

Serious or Rare Side Effects: - Severe allergic reactions such as anaphylaxis: rapid onset of hives, swelling, breathing difficulty - Stevens‑Johnson syndrome or toxic epidermal necrolysis: serious skin blistering and detachment - Suicidal thoughts or behavior: emergence of depressive mood or self‑harm ideation

When prescribing levetiracetam, several safety considerations should be reviewed to minimize risk. - Renal impairment: adjust dose based on creatinine clearance - Hepatic dysfunction: monitor liver enzymes regularly - Pregnancy: potential risk unknown; discuss benefits versus risks with a healthcare professional - Concomitant CNS depressants: may increase sedation and should be used cautiously - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight

Levetiracetam can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: induces metabolism, lowering levetiracetam plasma levels - Phenobarbital: reduces drug concentration through enzyme induction - Rifampin: increases clearance, potentially decreasing therapeutic effect

Moderate Interactions (Monitor Closely): - Alcohol: may enhance central nervous system depression - Other antiepileptics (e.g., valproate): may require dose adjustments based on clinical response